Connect with NIDA:

NIDA Notes Articles: People with HIV or AIDS

Sort by:
Date
|
Title

Journal Highlights Global Nexus of Drug Abuse and HIV/AIDS

October 2007
Reviews a journal supplement that compiles studies on drug-related HIV transmission, with a focus on injection drug use, in 16 different localities across the globe.

Latest Information on MDMA/Ecstasy, Steroids, and HIV/AIDS Is Available on NIDA's Web Site

April 2007
Announces updates to research reports on MDMA/ecstasy and steroids and a new report on HIV/AIDS that provide the latest available information on drugs and drug-related topics.

Researchers Report on Progress of NIDA's Southern Africa Initiative

March 2008
Presents an update on NIDA’s Southern African Initiative, a program that aims to build research capacity and infrastructure in the area of addiction, particularly drug-related HIV transmission.

Seek-Test-Treat-Retain To Stop the Spread of HIV

February 2013
Despite the advances in treatment and prevention, roughly 50,000 new HIV infections still occur annually in the Nation. Research, in large part supported by NIDA, has produced a strategy to address this circumstance and break the epidemiological impasse: seek out HIV-infected individuals, particularly those in “hard-to-reach” groups that have minimal contact with the health care system; offer them HIV testing and treatment; and provide support to help them stay in treatment.

Selenium Shows Promise as an Adjunct Therapy for HIV

December 2008
Reports on a randomized controlled trial of HIV-infected men and women who, as a result of receiving selenium supplements, experienced lower HIV viral load and greater CD4 cell count.

Study Endorses Onsite HIV Testing Without Risk Reduction Counseling

April 2013
Patients were more likely to take a rapid HIV test when substance abuse treatment programs offered the test onsite rather than referred for offsite testing. Patients were equally likely to accept and learn their HIV status whether the offer of onsite testing was accompanied by 30 minutes of risk reduction counseling or by 5 minutes of brief information on the testing procedure. Onsite testing accompanied by brief information was cost effective, taking into account the projected lifetime costs of treatment and the gains in health and longevity for detected cases.

Study Gives Green Light to Antiretroviral Medications for HIV-Infected Injection Drug Users

December 2009
Reports finding from a study showing that access to antiretroviral therapies, HAART in particular, can improve the health of HIV-infected patients who have a history of injection drug use.

Study: Treat Jail Detainees’ Drug Abuse To Lower HIV Transmission

March 2014
Active drug use before incarceration was associated with decreased engagement in HIV treatment among HIV-infected jail detainees. The severity of drug dependence correlated with worsening measures of engagement in HIV treatment. The study concludes that evidence-based treatment for drug abuse in jails may result in improved HIV treatment outcomes, which in turn could help slow HIV-transmission rates in the United States.

Menu

NIDA Notes Articles: People with HIV or AIDS

Journal Highlights Global Nexus of Drug Abuse and HIV/AIDS

Latest Information on MDMA/Ecstasy, Steroids, and HIV/AIDS Is Available on NIDA's Web Site

Researchers Report on Progress of NIDA's Southern Africa Initiative

Seek-Test-Treat-Retain To Stop the Spread of HIV

Selenium Shows Promise as an Adjunct Therapy for HIV

Study Endorses Onsite HIV Testing Without Risk Reduction Counseling

Study Gives Green Light to Antiretroviral Medications for HIV-Infected Injection Drug Users

Study: Treat Jail Detainees’ Drug Abuse To Lower HIV Transmission

Pages

Categories

Tags

Drug Topics

Drugs of Abuse

Population Groups

Related Topics